Collplant Biotechnologies
CLGN · NASDAQ
$3.88+$0.00 (+0.00%)TodayMarket closed ·
Prev close $3.88
Who owns CLGN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 38.0% of CLGN’s shares.
- Loewenbaum (Lilian Shaw)11.5%
- Sagy (Ami)8.7%
- Loewenbaum (George Walter II)6.7%
- Pinnacle Associates Ltd.3.9%
- Next 6 largest institutions7.3%
- All other shareholders62.0%
| Holder | Shares | % of shares |
|---|---|---|
| Loewenbaum (Lilian Shaw) | 2.17M | 11.48% |
| Sagy (Ami) | 1.64M | 8.66% |
| Loewenbaum (George Walter II) | 1.27M | 6.72% |
| Pinnacle Associates Ltd. | 731.66K | 3.87% |
| St. Denis J. Villere & Company, LLC | 606.40K | 3.21% |
| Evans (Hugh M) | 343.68K | 1.82% |
| AMH Equity, Ltd. | 200.00K | 1.06% |
| Brown Advisory | 104.73K | 0.55% |
| Renaissance Technologies LLC | 61.50K | 0.33% |
| Pathstone | 57.00K | 0.30% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 593 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CLGN in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Abelis Bar Berta | Award | 201.14K | — |
| Rotem Eran | Award | 510.37K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 42.22K
- Days to cover
- 1.00
- % of shares outstanding
- 0.22%
- Average daily volume
- 78.37K
- Change since last report
- −19.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.